Published in Biomed Res Int on March 19, 2015
Intravoxel Incoherent Motion MR Imaging for Staging of Hepatic Fibrosis. PLoS One (2016) 0.75
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology (1988) 8.08
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet (2001) 5.82
A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology (2006) 3.80
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology (2007) 3.73
Diffusion-weighted MR imaging of the liver. Radiology (2010) 3.50
Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol (2002) 2.55
Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology (1999) 2.19
Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol (2006) 2.17
Diffusion MR imaging: clinical applications. AJR Am J Roentgenol (1992) 2.12
FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis. Am J Gastroenterol (2014) 2.11
Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol (2007) 2.07
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol (2008) 2.05
Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol (2007) 2.02
Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q (1991) 1.85
Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology (2008) 1.73
Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62
Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci (1993) 1.52
Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging (2009) 1.50
Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology (2002) 1.45
Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging (2008) 1.44
Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol (2007) 1.39
Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology (2007) 1.37
Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol (2009) 1.36
Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging (2008) 1.35
Imaging of diffusion and microcirculation with gradient sensitization: design, strategy, and significance. J Magn Reson Imaging (1992) 1.23
Evaluation of hepatic focal lesions using diffusion-weighted MR imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived parameters. J Magn Reson Imaging (2013) 1.20
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®). J Hepatol (2013) 1.19
Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology (1999) 1.15
Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci (2005) 1.15
Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol (2010) 1.11
Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke (1992) 1.10
Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol (2011) 1.09
Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology (2011) 1.08
The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci (2006) 1.08
Echo-planar imaging of diffusion and perfusion. Magn Reson Med (1991) 1.07
Non-invasive assessment of liver fibrosis. Ann Gastroenterol (2012) 1.07
Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology (2008) 1.03
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol (2013) 1.02
Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol (2011) 1.02
Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging. Eur J Radiol (2009) 1.02
Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. J Comput Assist Tomogr (2009) 1.00
Diffusion/perfusion MR imaging of the liver: practice, challenges, and future. Magn Reson Med Sci (2012) 1.00
Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med (2006) 0.99
MR-diffusion weighted imaging of healthy liver parenchyma: repeatability and reproducibility of apparent diffusion coefficient measurement. J Magn Reson Imaging (2010) 0.97
Hepatic pseudo-anisotropy: a specific artifact in hepatic diffusion-weighted images obtained with respiratory triggering. MAGMA (2007) 0.94
Utilization of FibroScan in clinical practice. Curr Gastroenterol Rep (2014) 0.93
Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol (2014) 0.89
Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol (2014) 0.87
Evaluation of the biliary and pancreatic system with 2D SSFSE, breathhold 3D FRFSE and respiratory-triggered 3D FRFSE sequences. Radiol Med (2010) 0.85
[Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations]. Korean J Hepatol (2007) 0.80
Utility of navigator-prospective acquisition correction technique (PACE) for reducing motion in brain MR imaging studies. AJNR Am J Neuroradiol (2007) 0.79
Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases. Radiol Med (2014) 0.79
Diffusion-weighted MRI of the liver-Interpretative pearls and pitfalls. Clin Radiol (2012) 0.78
Diffusion-weighted MRI in a liver protocol: its role in focal lesion detection. World J Radiol (2012) 0.78
MR-diffusion imaging in assessing chronic liver diseases: does a clinical role exist? Radiol Med (2011) 0.77
Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T. Clin Radiol (2014) 0.76
Contrast-Enhanced Magnetic Resonance Cholangiography: Practical Tips and Clinical Indications for Biliary Disease Management. Gastroenterol Res Pract (2017) 0.75